The materials that protect and deliver medicines are changing.
asserted
that → protect → medicines
Therapies are becoming more sensitive, treatment is moving from the clinic to the patient, and regulatory and customer pressure is pushing the industry away from legacy materials such as fluoropolymers and talc.
asserted
pressure → become → fluoropolymers
At CPHI Milan 2026 (Stand 11F25, Packaging & Drug Delivery zone, October 6 to 8), TekniPlex Healthcare will show how its materials science helps pharmaceutical and consumer health companies stay ahead of all three shifts.
asserted
companies → show → shifts
The company’s presence at CPHI Milan is built around the theme “Protect the Therapy.
asserted
presence → build → Therapy
reflecting how TekniPlex Healthcare’s material science expertise supports pharmaceutical partners and healthcare brands at every stage, from safeguarding sensitive formulations to enabling new delivery mechanisms and improving patient outcomes.
asserted
expertise → reflect → outcomes
“Pharmaceutical innovation increasingly requires materials to do more from protecting highly sensitive therapies to enabling entirely new ways of delivering them,” said Brenda Chamulak, CEO of TekniPlex.
asserted
Chamulak → require → TekniPlex
“At CPHI Milan, we are demonstrating how TekniPlex Healthcare brings material science, manufacturing expertise and application knowledge together to help our customers address these evolving requirements.
asserted
customers → demonstrate → requirements
Designed for moisture and oxygen-sensitive therapies, Flexapharm SBC delivers PCTFE-level moisture protection with superior oxygen barrier performance while providing a PFAS-free alternative to traditional fluoropolymer-based structures.
asserted
SBC → design → structures
The thermoformable film is available in multiple coating weights, constructions, substrates and colors, allowing the barrier to be tailored to specific product requirements.
asserted
barrier → allow → requirements
Lower processing and sealing temperatures, combined with improved forming performance, can also help manufacturers increase production efficiency and reduce energy use.
asserted
manufacturers → combine → use
Flexapharm SBC’s transparent construction provides product visibility while maintaining high-barrier performance.
asserted
construction → provide → performance
Its compact high-barrier structures require less material than traditional PCTFE-based films, translating to a significant reduction in carbon footprint alongside reduced transportation, warehousing and storage needs.
asserted
structures → require → needs
Cleaner Materials for Consumer Health Dispensing
The same shift is reaching the components inside consumer health dispensing systems.
asserted
shift → reach → systems
TekniPlex Healthcare’s ClearCycle+™ stem gaskets need no talc or silicone surface treatment, giving manufacturers a non-stick alternative that supports cleaner, more stable and more efficient production.
asserted
that → need → production
FDA-compliant, ClearCycle+ helps customers meet tighter material requirements without sacrificing line performance.
asserted
customers → help → performance
Enabling the Next Generation of Wearable Drug Delivery
TekniPlex Healthcare will also showcase its flexible film reservoir technology for wearable liquid drug delivery, developed to combine the barrier protection required for sensitive biologics with the flexibility and design freedom needed for next-generation on-body devices.
asserted
Healthcare → enable → devices
High-barrier film structures help protect sensitive formulations from moisture and oxygen, while thermoformable reservoirs can be shaped around the required dose, device architecture, and patient experience.
asserted
reservoirs → help → dose
Thin, lightweight and break resistant film formats can support the development of smaller, lighter and more comfortable wearable devices.
asserted
formats → support → devices
The platform builds on TekniPlex Healthcare’s expertise in barrier films, sealing technologies and medical-grade processing.
asserted
platform → build → films
The company’s third major focus at CPHI Milan will be its growing ophthalmic solutions portfolio, which connects advanced materials, precision components and drug delivery solutions across the ophthalmic ecosystem.
asserted
which → grow → ecosystem
TekniPlex Healthcare offers high-barrier materials designed to protect moisture and oxygen sensitive ophthalmic formulations, along with materials and systems supporting sterility from filling through final product use.
asserted
Healthcare → offer → use
Beyond materials engineered for optical clarity, surface quality and formulation compatibility, the portfolio reflects TekniPlex Healthcare’s broader ophthalmic ecosystem approach, encompassing drug delivery solutions and R&D and development support that help customers respond to evolving formulation and regulatory requirements.
asserted
customers → engineer → requirements
By bringing these capabilities together, TekniPlex Healthcare aims to provide pharmaceutical and medical device companies with one integrated materials science partner from material selection through delivery.
asserted
Healthcare → bring → delivery
###
About TekniPlex Healthcare
TekniPlex Healthcare utilizes advanced materials science expertise and technologies to develop and deliver critical solutions for medical and diagnostic devices, drug delivery systems and sterile barrier healthcare packaging applications.
asserted
Healthcare → utilize → devices
With a global reach, the division’s deep understanding of the greater pharmaceuticals and medical landscape helps it produce exemplary barrier properties for drugs and precision medical devices for interventional and therapeutic procedures.
asserted
it → help → procedures
In the medical device niche, TekniPlex Healthcare embodies a comprehensive CDMO partner capable of servicing every stage of the product life cycle, from design and development through component manufacturing and final assembly.
asserted
Healthcare → embody → manufacturing
Throughout its broad purview, the division’s ever-evolving portfolio helps meet demands for high-leverage medicines and mission-critical healthcare products that benefit care providers and patients.
asserted
that → evolve → providers
The Aporia
